Reduced immunoglobulin kappa/lambda light chain ratio in perinatally HIV-1-infected children

M Saitta1, F Gaido, E Palomba

  • 1Laboratory of Clinical Chemistry and Microbiology, Regina Margherita Children's Hospital, Turin, Italy.

Insights

Children with perinatal human immunodeficiency virus type 1 (HIV-1) infection show a consistent bias toward producing lambda light chains over kappa light chains. This finding contributes to understanding B-cell abnormalities in pediatric HIV-1.

Area of Science:

  • Immunology
  • Virology
  • Pediatrics

Background:

  • Perinatal human immunodeficiency virus type 1 (HIV-1) infection can lead to B-cell abnormalities.
  • The kappa/lambda light chain ratio (KLR) is a novel laboratory index assessing immunoglobulin light chain synthesis balance.

Purpose of the Study:

  • To investigate the serum immunoglobulin kappa/lambda light chain ratio (KLR) in children with perinatal HIV-1 infection.
  • To determine if HIV-1 infection status or therapy affects KLR.

Main Methods:

  • Serum samples from 27 perinatally HIV-1-infected children were analyzed.
  • Immunonephelometry was used to measure the kappa/lambda light chain ratio (KLR).
  • KLR was compared to age-matched healthy controls.

Main Results:

  • KLR was consistent over time within individual subjects.
  • HIV-1-infected children had a significantly lower KLR compared to controls.
  • This difference was observed regardless of disease status or therapy.

Conclusions:

  • Children with perinatal HIV-1 infection exhibit a bias towards producing lambda light chains over kappa light chains.
  • This altered light chain production is a contributing factor to B-cell abnormalities in pediatric HIV-1.
  • KLR serves as a potential indicator of immune dysregulation in HIV-1-infected children.